Ten-Year (2001-2011) Trends in the Incidence Rates and Short-Term Outcomes of Early Versus Late Onset Cardiogenic Shock After Hospitalization for Acute Myocardial Infarction by Nguyen, Hoa L. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2017-06-07 
Ten-Year (2001-2011) Trends in the Incidence Rates and Short-
Term Outcomes of Early Versus Late Onset Cardiogenic Shock 
After Hospitalization for Acute Myocardial Infarction 
Hoa L. Nguyen 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Cardiology Commons, Cardiovascular Diseases Commons, Clinical Epidemiology 
Commons, and the Epidemiology Commons 
Repository Citation 
Nguyen HL, Yarzebski JL, Lessard DM, Gore JM, McManus DD, Goldberg RJ. (2017). Ten-Year (2001-2011) 
Trends in the Incidence Rates and Short-Term Outcomes of Early Versus Late Onset Cardiogenic Shock 
After Hospitalization for Acute Myocardial Infarction. Open Access Articles. https://doi.org/10.1161/
JAHA.117.005566. Retrieved from https://escholarship.umassmed.edu/oapubs/3185 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
Ten-Year (2001–2011) Trends in the Incidence Rates and Short-Term
Outcomes of Early Versus Late Onset Cardiogenic Shock After
Hospitalization for Acute Myocardial Infarction
Hoa L. Nguyen, MD, MS, PhD; Jorge Yarzebski, MD, MPH; Darleen Lessard, MS; Joel M. Gore, MD; David D. McManus, MD, MS;
Robert J. Goldberg, PhD
Background-—Cardiogenic shock (CS) is a serious complication of acute myocardial infarction, and the time of onset of CS has a
potential role in inﬂuencing its prognosis. Limited contemporary data exist on this complication, however, especially from a
population-based perspective. Our study objectives were to describe decade-long trends in the incidence, in-hospital mortality, and
factors associated with the development of CS in 3 temporal contexts: (1) before hospital arrival for acute myocardial infarction
(prehospital CS); (2) within 24 hours of hospitalization (early CS); and (3) ≥24 hours after hospitalization (late CS).
Methods and Results-—The study population consisted of 5782 patients with an acute myocardial infarction who were admitted to
all 11 hospitals in central Massachusetts on a biennial basis between 2001 and 2011. The overall proportion of patients who
developed CS was 5.2%. The proportion of patients with prehospital CS (1.6%) and late CS (1.5%) remained stable over time,
whereas the proportion of patients with early CS declined from 2.2% in 2001–2003 to 1.2% in 2009–2011. In-hospital mortality for
prehospital CS increased from 38.9% in 2001–2003 to 53.6% in 2009–2011, whereas in-hospital mortality for early and late CS
decreased over time (35.9% and 64.7% in 2001–2003 to 15.8% and 39.1% in 2009–2011, respectively).
Conclusions-—Development of prehospital and in-hospital CS was associated with poor short-term survival and the in-hospital
death rates among those with prehospital CS increased over time. Interventions focused on preventing or treating prehospital and
late CS are needed to improve in-hospital survival after acute myocardial infarction. ( J Am Heart Assoc. 2017;6:e005566. DOI:
10.1161/JAHA.117.005566.)
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C ardiogenic shock (CS) is a serious complication of acutemyocardial infarction (AMI).1–6 The frequency of CS has
either slightly declined or remained unchanged over time, with
reported rates ranging from 3% through 10%, depending, in
part, on the deﬁnitions used to deﬁne CS and the character-
istics of the populations studied.7–11 Although the hospital
case-fatality rates associated with CS have encouragingly
declined over time, CS remains a major cause of death among
patients hospitalized with AMI.7–11
Understanding the magnitude and impact of the timing of
CS, and factors associated with the time of onset of CS, are
crucial to identifying patients at increased risk for this serious
clinical complication and enhancing their prognosis. Previous
studies have shown that a minority of patients with AMI
developed CS before hospital admission, whereas the majority
developed this complication during their acute hospitalization,
especially during the ﬁrst 24 hours.7,9,12–16 The pathophys-
iology, hospital management, and outcomes associated with
CS are likely to be different for patients who develop this
complication prehospital or at varying time intervals during
hospitalization for AMI. However, data in this area are very
limited or from the distant past.7,14–16
In several previous publications from our population-based
coronary heart disease surveillance system among residents of
central Massachusetts, we examined trends in the incidence
and hospital case-fatality rates associated with in-hospital CS
among patients hospitalized with AMI.4–6,8 The objectives of the
present study were to describe relatively contemporary decade-
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long trends (2001–2011) in the incidence and in-hospital death
rates associated with the timing of CS (prehospital, early during
hospitalization, and late) in patients hospitalized with AMI and
explore factors associated with the timing of CS.
Methods
The Worcester Heart Attack Study is an ongoing population-
based investigation that is examining long-term trends in the
descriptive epidemiology of AMI among residents of the
Worcester, Massachusetts, metropolitan area hospitalized at
all medical centers in central Massachusetts on an approx-
imate biennial basis.2,3,17,18 All data collected from the
hospital medical records of patients with independently
validated AMI in this population-based clinical/epidemiolog-
ical investigation are independently reviewed by experienced
physician and nurse reviewers and validated to the extent
possible. This is in contrast to information that is recorded in
an administrative database, which is often neither indepen-
dently reviewed nor validated in a standardized manner.
Computerized printouts of patients discharged from all
greater Worcester hospitals with possible AMI (International
Classiﬁcation of Disease, Ninth Revision codes: 410–414,
786.5) were identiﬁed and cases of AMI were independently
validated using predeﬁned criteria.2,3,17,18 We reviewed the
medical records of all consecutive geographically eligible (eg,
resident of central Massachusetts) patients who were hospi-
talized for AMI at all 11 central MA medical centers during the
years under study. Diagnoses of ST-segment elevation
myocardial infarction (STEMI) and non-ST segment elevation
myocardial infarction (NSTEMI) were made using standardized
criteria.19
Trained nurses and physicians abstracted information on
patients’ demographic and clinical characteristics and hospi-
tal treatment practices through the review of hospital medical
records. These factors included patients’ age, sex, race/
ethnicity, mode of transportation, hospital length of stay,
history of previously diagnosed comorbidities and cardiac
procedures, AMI type (STEMI versus NSTEMI) and order (initial
versus previous), clinical signs and symptoms, and laboratory
ﬁndings on admission.20,21 Information on the development of
important in-hospital complications, including atrial ﬁbrilla-
tion,22 CS,6 heart failure,23 and stroke,24 was collected.
Patients with a systolic blood pressure of <80 mm Hg in
the absence of hypovolemia and associated with cyanosis,
cold extremities, changes in mental status, persistent
oliguria, or congestive heart failure, as recorded in hospital
medical records, were deﬁned as having CS.4–6 The deﬁni-
tion of CS remained the same during all periods studied.
This disorder was deﬁned so that patients with classic signs
and symptoms of this clinical syndrome would be included.
Data on cardiac index or left ventricular ejection fraction
ﬁndings were not included as part of our working deﬁnition
for CS in this study. In the present analysis, because the
exact time of onset of AMI was not possible to be precisely
determined, CS was categorized into 3 distinct groups based
on time of admission: prehospital; early (during the ﬁrst
24 hours after admission); and late shock (≥24 hours after
hospital admission).
Data on the receipt of 3 coronary diagnostic and
interventional procedures (cardiac catheterization, percuta-
neous coronary intervention [PCI], and coronary artery bypass
grafting [CABG]), intra-aortic balloon pump (IAPB) support, and
various pharmacotherapies during hospitalization, including
angiotensin converting inhibitors/angiotensin receptor block-
ers, aspirin, beta-blockers, and lipid-lowering agents, were
obtained. Patients with a diagnosis of AMI associated with an
interventional procedure were not included in this study.
Statistical Analysis
We estimated the incidence of CS for the 3 temporally
characterized groups (prehospital, early, and late) in a
standard manner. We compared patient characteristics,
hospital management practices, in-hospital clinical
Clinical Perspective
What is New?
• The results of this community-wide study provide insights
into the magnitude of CS, the timing of its occurrence, and
its impact on in-hospital death rates among patients
hospitalized with AMI overall and over time.
• The proportion of patients who developed prehospital or late
(>24 hours after hospital admission) CS remained stable,
whereas the proportion of patients who developed early CS
increased and subsequently decreased between the most
distant and recent study years.
• The in-hospital death rates were 46%, 33%, and 54%,
respectively, for those with prehospital, early, and late CS.
What are the Clinical Implications?
• Clinicians should remain diligent about the prevention of
this signiﬁcant clinical syndrome and treat patients with AMI
who develop this condition as soon as possible, especially
those who develop CS later during their acute hospital stay.
• We found differences in the sociodemographic and clinical
factors associated with the timing of CS, which reinforces
the need for a more-detailed assessment of possible
predisposing factors that may lead to the development of
this serious clinical syndrome at varying time intervals after
hospitalization for AMI.
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complications, and in-hospital case-fatality rates (CFRs) in the
3 CS groups using chi-square tests for categorical variables
and ANOVA tests for continuous variables.
In examining factors associated with the development of
CS at different time points, we used a multivariable
multinomial logistic regression model (with patients who
did not develop CS serving as the reference group), including
age, sex, ambulance transportation, previously diagnosed
comorbidities, past cardiac procedures, and AMI type and
order. Because we were unable to determine the relationship
between the timing of development of other clinical compli-
cations during hospitalization and the onset of CS, we did
not include other clinical complications in this regression
model.
In examining the association between the timing of CS and
in-hospital death rates, we used multivariable logistic regres-
sion models to control for the effects of several sociodemo-
graphic and clinical factors of prognostic importance. These
factors were chosen based on the ﬁndings from previously
published studies and because they differed between our
primary comparison groups of patients with CS at a P value of
<0.20. These factors included age, sex, study year, hospital
transportation, previously diagnosed comorbidities (eg, ang-
ina, diabetes mellitus, heart failure, hypertension, and stroke),
past cardiac procedures (PCI, CABG), AMI type (STEMI versus
NSTEMI) and order (initial versus prior), other clinical compli-
cations that patients may have developed during their acute
hospitalization (eg, atrial ﬁbrillation, heart failure, and stroke),
and hospital length of stay.
All analyses were performed using SAS software (version
9.3; SAS Institute Inc, Cary, NC). This study was approved by
the institutional review board at the University of Mas-
sachusetts Medical School (Worcester, MA).
Results
The study population consisted of 5782 patients hospitalized
with AMI at the 11 tertiary care and community medical
centers in central Massachusetts on a biennial basis between
2001 and 2011. The average age of this study population was
70 years old and 56.6% were men.
Trends in Incidence Rates According to Timing of
CS
The overall proportion of residents of the Worcester
metropolitan area who were hospitalized for AMI at all central
MA medical centers who developed CS was 5.2%; there was a
slightly increasing trend in the frequency of CS in this
population between 2001–2003 (5.1%) and 2005–2007
(6.0%) and a decreasing trend thereafter to 4.4% in
2009–2011. The proportion of patients who developed either
prehospital (1.6%) or late CS (1.5%) remained relatively
unchanged over time (Figure 1). The proportion of patients
who developed early CS increased between 2001–2003
(2.2%) and 2005–2007 (2.9%) and declined thereafter to 1.2%
in 2009–2011.
Among the 1853 patients who were diagnosed with a
STEMI, 2.5% developed CS before admission, 4.3% during the
ﬁrst day of hospitalization, and 2.1% after this time; these
proportions were 1.2% at each of these 3 time points among
the 3929 patients who developed an NSTEMI (P<0.001).
Trends in Hospital Death Rates According to
Timing of CS
The overall in-hospital CFR associated with CS was 42.7%.
The overall in-hospital 2CFRs for patients with prehospital,
early, and late CS were 45.7%, 32.8%, and 54.1%, respec-
tively. The in-hospital CFRs associated with prehospital CS
increased from 38.9% in 2001–2003 to 53.6% in 2009–2011
(Figure 2), whereas the in-hospital CFRs associated with
early or late CS declined (35.9% and 64.7% in 2001–2003 to
15.8% and 39.1% in 2009–2011, respectively) over this
period.
Among patients who were diagnosed with an STEMI, 46.8%
of those who developed CS before admission (n=47) died
during their acute hospitalization compared with 77.2% of
those who developed CS during the ﬁrst 24 hours of
admission (n=79) and 53.9% of the 39 who developed CS
thereafter (P<0.001). Among patients with an NSTEMI, 55.6%
of the 45 who developed CS before admission died, 50.0% of
the 46 who developed CS during the ﬁrst 24 hours of
admission died, whereas 39.1% of the 46 who developed CS
thereafter died (P<0.001).
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Figure 1. Temporal trends (2001–2011) in the incidence rates
of cardiogenic shock.
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Patient Characteristics According to Timing of CS
Patients who developed CS were older than those who did not
develop shock; patients in the late shock group were the
oldest (Table 1). Patients with CS were more likely to have a
do not resuscitate order, to have been transferred to all
greater Worcester medical centers by ambulance, and to have
been previously diagnosed with diabetes mellitus and heart
failure (with the exception of the early CS patients), as
compared with patients who did not develop CS. Patients who
developed late onset CS were more likely to have been
previously diagnosed with hypertension and stroke as com-
pared with patients who did not develop this serious clinical
complication. However, patients who developed prehospital
CS were less likely to have a history of stroke, whereas
patients who developed early CS were less likely to have had
hypertension and stroke previously diagnosed, as compared
with patients who did not develop this complication. Patients
who developed early and late onset CS were more likely,
whereas patients who developed prehospital CS were less
likely, to have undergone cardiac catheterization and a
subsequent PCI and/or CABG compared with patients who
did not develop this complication.
On admission, patients who developed prehospital and late
CS were less likely to have reported chest pain, more likely to
have been diagnosed with an STEMI, and had lower systolic
and diastolic blood pressure, estimated glomerular ﬁltration
rate, and blood cholesterol ﬁndings, but higher heart rate and
blood glucose levels, as compared with patients who did not
develop CS (Table 1).
Factors Associated With the Time of Onset of CS
After multivariable adjustment, patients aged 65 to 74 years
were more likely to have developed early CS, whereas
patients aged 75 years or older were more likely to have
developed late CS, compared with younger patients
(Table 2). Patients transported by ambulance were more
likely, whereas those with a history of previously diagnosed
stroke were less likely, to have developed prehospital and
early CS compared with respective comparison groups.
Patients with a history of previously diagnosed diabetes
mellitus were more likely to have developed prehospital CS
compared with those without this comorbid condition.
Patients presenting with an STEMI were more likely to have
developed CS at all 3 time points examined than patients
who developed an NSTEMI.
In-Hospital Management Practices According to
Timing of CS
The proportion of patients who were treated with various
cardiac medications was signiﬁcantly lower in patients with
prehospital and early CS (with the exception of angiotensin
converting inhibitors/angiotensin receptor blockers in early
shock patients), but higher in patients who developed CS at a
later time (with the exception of beta-blockers) than among
patients who did not develop CS (Table 3). The proportion of
patients who underwent cardiac interventional procedures
was lower in patients who developed prehospital CS, but
higher in patients who developed either early or late CS, than
patients who did not develop CS. The proportion of patients
who received IABP support was higher in all patients who
developed CS, and highest in patients who developed CS early
during their hospitalization, compared with patients who did
not develop CS. Although we were unable to determine
whether coronary reperfusion/revascularization therapy
occurred before or after the development of CS when these
entities occurred on the same hospital day, we did collect
information about whether or not a PCI or CABG surgery was
performed within 24 hours of hospital arrival.
Among patients with prehospital CS, 38% of patients
underwent a PCI compared with 23.5% of patients with late
shock. Among patients with an STEMI, these percentages
were 55.3% and 41%, respectively, among those with
prehospital and late CS; these proportions were 20% and
8.7% among those with an NSTEMI. With regard to CABG
surgery, 1.1%, and 2.4% of patients with prehospital and late
CS underwent this procedure. These percentages were 0%
and 2.6% for patients with an STEMI and 2.2% and 2.2% for
patients with an NSTEMI.
In-Hospital Clinical Complications and Death
According to Timing of CS
Patients who developed CS at all 3 time points were more
likely to have developed other important clinical
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Figure 2. Temporal trends (2001–2011) in in-hospital
case-fatality rates associated with cardiogenic shock.
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complications in comparison to patients who did not develop
CS during their index hospitalization; the highest rates of
these complications were observed in patients who developed
late CS with the exception of third-degree atrioventricular
block, which was more likely to occur in patients who
developed prehospital CS (Table 4). Similarly, the in-hospital
CFR were signiﬁcantly higher in patients who did, as
compared with those who did not, develop CS; the highest
in-hospital mortality was observed in the late CS group,
followed by patients with prehospital and early CS.
Table 1. Patient Characteristics According to Timing of CS in Patients Hospitalized With AMI
Prehospital
CS (n=92)
Early CS
(n=125)
Late CS
(n=85)
No CS
(n=5480) P Value
Age (mean, y) 70.9 71.1 76.1 69.8 <0.01
Age groups, %
<65 y 26.1 28.0 14.1 33.8 <0.01
65 to 74 y 23.9 29.6 23.5 20.2
≥75 y 50.0 42.4 62.4 46.0
Male, % 54.4 60 45.9 56.8 0.19
Any DNR, % 45.7 34.4 37.7 22.9 <0.001
Ambulance transportation, % 84.8 80.8 72.9 67.7 <0.001
Prehospital delay duration (mean, h) 3.0 2.9 5.9 3.8 0.09
Medical history, %
Angina 13.0 13.6 17.7 14.4 0.83
Diabetes mellitus 46.7 36.0 50.6 30.5 0.002
Heart failure 29.4 19.2 36.5 23.5 0.02
Hypertension 73.9 68.0 88.2 73.8 0.01
Stroke 6.5 3.2 15.3 11.8 0.006
Cardiac procedure history, %
Catheterization 58.7 81.6 64.7 61.2 <0.001
Percutaneous coronary intervention (PCI) 19.6 21.6 25.9 20.1 0.61
Coronary artery bypass grafting (CABG) 14.1 13.6 16.5 13.5 0.89
Both PCI and CABG 0.0 3.2 2.4 0.7 0.02
Presenting symptoms, %
Chest pain 54.4 73.6 62.4 73.3 <0.001
Diaphoresis 29.4 33.6 18.8 29.6 0.12
Shortness of breath 60.9 60.8 63.5 55.6 0.22
AMI characteristics
STEMI, % 51.1 63.2 45.9 30.8 <0.001
Initial 69.6 67.2 52.9 64.7 0.10
Clinical parameters on admission, mean
Systolic blood pressure, mm Hg 117.1 117.8 130.9 142.3 <0.001
Diastolic blood pressure, mm Hg 68.3 68.0 72.3 77.5 <0.001
Heart rate, beats/minute 86.4 89.2 89.7 85.8 0.17
Laboratory findings on admission, mean
Blood glucose, mg/dL 225.2 205.0 189.0 169.8 <0.001
Estimated GFR, % 45.9 52.1 47.1 56.6 <0.001
Blood cholesterol, mg/dL 148.3 156 154.3 171.3 <0.001
AMI indicates acute myocardial infarction; CS, cardiogenic shock; DNR, do not resuscitate; GFR, glomerular ﬁltration rate; STEMI, ST-segment elevation myocardial infarction.
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The results of our multivariable adjusted logistic regression
analyses, which controlled for a number of potentially con-
founding factors of prognostic importance, showed that
patients who developed CS before hospital arrival and at any
time during hospitalizationwere signiﬁcantlymore likely to have
died compared with those who did not develop CS. Late CS was
associatedwith the highest risk of dying during the hospital stay
(adjusted odds ratio, 22.20; 95% CI, 12.25–40.22) followed by
prehospital CS (adjusted OR, 9.19; 95% CI, 5.31–15.91) and
early CS (adjusted odds ratio, 7.92; 95% CI, 5.04–12.46).
Table 3. Hospital Management Practices According to Timing of CS in Patients Hospitalized with AMI
Prehospital
CS (n=92)
Early CS
(n=125)
Late CS
(n=85)
No CS
(n=5480) P Value
In-hospital medications, %
ACEi/ARBs 44.6 64.8 65.9 64.8 <0.001
Aspirin 79.4 90.4 97.7 92.0 <0.001
Beta-blockers 64.1 77.6 85.9 90.5 <0.001
Calcium-channel blockers 14.1 12.0 28.2 22.3 <0.005
Lipid-lowering agents 58.7 64.8 76.5 73.7 <0.001
In-hospital cardiac procedures, %
Catheterization 58.7 81.6 64.7 61.2 <0.001
Percutaneous coronary intervention 44.6 67.2 43.5 43.0 <0.001
Coronary artery bypass grafting 3.3 8.0 12.9 6.3 <0.05
Intra-aortic balloon pump 41.3 60.0 42.4 3.5 <0.001
ACEi indicates angiotensin converting enzyme inhibitors; AMI, acute myocardial infarction; ARBs, angiotensin II receptor blockers; CS, cardiogenic shock.
Table 2. Factors Associated With the Timing of CS in Patients Hospitalized With AMI
Prehospital CS Early CS Late CS
Odds Ratio (95% CIs)
Age groups, y
<65 1.00 1.00 1.00
65 to 74 1.55 (0.79–3.07) 2.23 (1.30–3.82)* 2.26 (0.95–5.36)
≥75 0.99 (0.52–1.93) 1.49 (0.87–2.53) 2.93 (1.34–6.40)*
Male 1.18 (0.70–1.99) 0.87 (0.59–1.32) 1.03 (0.61–1.74)
Ambulance transportation 2.89 (1.40–5.95)* 2.21 (1.32–3.69)* 1.14 (0.62–2.08)
Medical history
Angina 0.81 (0.40–1.64) 0.84 (0.48–1.48) 0.90 (0.47–1.74)
Diabetes mellitus 2.04 (1.21–3.46)* 1.17 (0.75–1.82) 1.68 (0.99–2.86)
Heart failure 1.36 (0.74–2.47) 0.91 (0.54–1.54) 1.40 (0.79–2.48)
Hypertension 0.98 (0.54–1.79) 0.84 (0.53–1.31) 1.53 (0.75–3.11)
Stroke 0.29 (0.09–0.93)* 0.28 (0.10–0.78)* 0.93 (0.45–1.92)
Cardiac procedure history
Percutaneous coronary intervention 1.17 (0.55–2.50) 1.35 (0.74–2.47) 1.07 (0.52–2.21)
Coronary artery bypass grafting 1.00 (0.49–2.06) 1.24 (0.71–2.19) 1.30 (0.67–2.51)
AMI characteristics
STEMI 2.66 (1.58–4.49)* 3.57 (2.34–5.44)* 2.93 (1.73–4.96)*
Initial 1.18 (0.65–2.15) 1.01 (0.62–1.64) 0.89 (0.50–1.58)
AMI indicates acute myocardial infarction; CS, cardiogenic shock; STEMI, ST-segment elevation myocardial infarction.
*Statistically signiﬁcant.
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Discussion
The results of this study of 5800 patients hospitalized with
AMI at all 11 medical centers in central Massachusetts
between 2001 and 2011 showed that the frequency of
prehospital, early, and late CS has remained either unchanged
or inconsistently varied during the years under study. The
short-term CFRs associated with prehospital CS have
increased, whereas the in-hospital CFRs associated with early
and late CS have declined, during the years under study. Late
CS was associated with the highest risk of dying during
hospitalization followed by prehospital and early CS.
Trends in Incidence Rates According to Timing of
CS
We showed that the frequency of prehospital CS among
patients hospitalized with AMI has remained essentially
unchanged (1.6%) during the years under study, results which
are consistent with the ﬁndings from previous studies.7,9,15
For example, a study of nearly 300 000 patients with an
STEMI who were enrolled in the National Registry of
Myocardial Infarction showed that the frequency of CS at
the time of hospital admission remained relatively unchanged
(2.5%) between 1995 and 2004.7 Similarly, data from the
AMIS (Acute Myocardial Infarction in Switzerland) Plus
registry showed that the incidence rates of CS at the time
of hospital admission remained stable (2.3%) between 1997
and 2006.9 Of note, the frequency of prehospital CS in
previous studies was slightly higher than that observed in our
study, which may be attributed to differences in the respec-
tive study populations and working deﬁnitions of AMI and CS
utilized. Similar relatively stable trends in the incidence rates
of CS at the time of hospital presentation were noted in the
multicenter GRACE (Global Registry of Acute Coronary Events)
study, which included more than 65 000 patients who were
hospitalized with an acute coronary syndrome between 1999
and 2007.15
We found that the frequency of late CS remained
relatively unchanged (1.5%), whereas the incidence of
early-onset CS increased in early years and declined during
later study years. A limited number of studies have
examined the timing of CS during hospitalization for
AMI,12,13 but none have examined changing trends in the
magnitude of this condition according to its timing. In the
MILIS (Multicenter Investigation of the Limitation of Infarct
Size) study, which included nearly 850 patients with AMI in
the 1980s, the incidence of in-hospital CS was 7.1%, and
one half of these patients developed shock ≥24 hours after
hospital admission.13 Similarly, in a study of 6000 patients
hospitalized with AMI in 13 coronary care units in Israel
between 1981 and 1983, 2.6% of patients developed CS
during their hospitalization and two thirds of these patients
developed this complication ≥24 hours after hospital admis-
sion.12 Of note, these studies included a single study time
point and data from more-distant years.
If we combined our data for patients with early- and late-
onset CS, our ﬁndings are in agreement with the results from
previous studies, which have shown that the incidence of in-
hospital CS has declined over time.9,15 In the AMIS Plus
registry, the frequency of in-hospital CS decreased from
10.6% in 1997 to 2.7% in 2006.9 Similarly, there was a
declining trend in the frequency of in-hospital CS between
1999 and 2007 (5.1% versus 3.6%) in the GRACE study.15
Data from 3 national French registries of more than 7500
patients hospitalized with AMI in 1995, 2000, and 2005 also
showed declines in the prevalence of CS over time from 6.9%
in 1995 to 5.7% in 2005.25 However, data from the National
Registry of Myocardial Infarction showed that the incidence of
this complication during hospitalization remained unchanged
(6.1%) or even slightly increased between 1995 and 20047; of
note, this latter study only included patients with an STEMI. It
remains important to more fully understand the clinical
epidemiology and pathophysiological processes underlying
the timing of CS, including their underlying pathogenesis,
which has implications for the enhanced prevention, diagno-
sis, management, and prognosis of these patients.
Trends in Hospital Death Rates According to
Timing of CS
We found that the in-hospital CFRs associated with prehos-
pital CS increased between 2001–2003 and 2009–2011
(38.9% to 53.6%), which is consistent with ﬁndings from the
GRACE study.15 In contrast, the AMIS Plus registry showed
that the CFRs associated with CS at the time of hospital
presentation declined between 1997 and 2006 (62.8% to
47.7%).9
Table 4. In-Hospital Clinical Complications and Death
According to Timing of CS
Prehospital
CS (n=92)
Early CS
(n=125)
Late CS
(n=85)
No CS
(n=5480) P Value
In-hospital complications, %
Third-degree
atrioventricular
block
13.0 4.0 5.9 1.4 <0.001
Atrial fibrillation 32.6 44.0 49.4 19.1 <0.001
Heart failure 66.3 76.8 77.7 34.9 <0.001
Stroke 2.2 1.6 3.5 1.6 0.68
Death 45.7 32.8 54.1 7.3 <0.001
CS indicates cardiogenic shock.
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The worsening trend in short-term death rates for patients
who developed prehospital CS in our study is unclear, but of
concern. Whereas the in-hospital CFRs improved over time for
those with in-hospital CS, perhaps as a result of early and
more-effective treatment approaches, patients suffering pre-
hospital CS experienced poorer outcomes. One potential
explanation for this observation is that patients hospitalized
with AMI in recent years have a greater burden of comorbid
conditions present coupled with less-than-optimal care-
seeking behaviors and prolonged prehospital delay times.8
Another possible reason for our ﬁnding, which is supported by
the observation that fewer patients with prehospital CS
underwent an invasive procedure during their hospitalization
than did participants free from prehospital CS, is that patients
with prehospital CS were deemed to be too sick and at too
high risk at the time of hospital admission to receive selected
therapies.
Our study reinforces the need for more attention to be
directed to patients who develop CS in the prehospital setting
in clinical guidelines, research, and clinical practice and
emphasis placed on the more-aggressive use of early
revascularization in these high-risk patients.26–31 The use of
IABP is recommended,31,32 and although newer interventional
devices have provided better hemodynamic support than the
use of conventional IABP, none of these devices have yet been
shown to favorably improve survival compared with the use of
IABP.33,34
The in-hospital CFRs associated with early or late CS in the
present study declined between 2001–2003 and 2009–2011,
which are consistent with the results of previous studies.7,9,15
In the AMIS Plus study, the hospital CFRs for CS developing
during hospitalization for AMI declined from 60.9% to 48.9%
between 1997 and 2006.9 Similarly, declines in the hospital
death rates associated with CS were observed in the National
Registry of Myocardial Infarction between 1995 and 2004
(60.3% to 47.9%)7 and in 3 nation-wide French registries of
more than 7500 patients hospitalized with AMI in 1995, 2000,
and 2005.25
Previous studies have suggested that the declining trend in
mortality associated with CS complicating AMI was mainly
attributed to the early and aggressive use of evidence-based
medications and coronary interventions, including the use of
balloon pumps.7–11,25,26,28,35 However, a recent report from
the National Cardiovascular Database Registry Cath-PCI
registry, which included more than 56 000 patients with CS
complicating AMI who underwent a PCI within 24 hours from
acute symptom onset, showed that the hospital death rate for
this patient group increased between 2005–2006 (27.6%) and
2011–2013 (30.6%).36 This ﬁnding highlights the importance
of additional research into the use of various therapeutic
approaches to improve the short-term outcomes for patients
who develop CS.
Factors Associated With the Time of Onset of CS
We found that older patients, patients transported by
ambulance, those with a history of previously diagnosed
diabetes mellitus, and patients who presented with an STEMI
were more likely to develop CS compared with respective
comparison groups. These ﬁndings are consistent with the
results from previous studies9,13–15 On the other hand,
patients who had a history of previously diagnosed stroke
were less likely to have developed prehospital and early CS. In
the GRACE study, the frequency of having a previous stroke
was higher in patients who developed in-hospital CS than in
patients who did not develop CS15 whereas results from the
SPRINT (Systolic Blood Pressure Intervention Trial) study
found that a history of stroke was an independent predictor
for the development of in-hospital CS.12
The results of our study reinforce the need for a more-
detailed examination of the factors associated with CS,
including the role of other factors, such as prehospital
management practices, patient’s sociodemographic charac-
teristics, comorbid conditions, size of the acute infarct, and
impact of coronary reperfusion therapy, to provide insights
into clinical practice guidelines to assist in the secondary
prevention of this serious complication. This is a complicated
undertaking given the heterogeneity of patients who develop
CS and possible differing underlying mechanisms involved
that lead to the development of this serious clinical syndrome.
Our ﬁndings also emphasize the relevance of educating
paramedics to promptly recognize the development of CS and
initiate treatment of this condition during ambulance trans-
port to a nearby hospital for the management of AMI.
In-Hospital Management According to Timing of
CS
Our study found that the proportion of patients who were
treated with various cardiac medications was lower in patients
with prehospital and early CS, but higher in patients who
developed late-onset shock in comparison to patients who did
not develop CS. Of note, several of these medications are
often withheld because of the presence of hypotension,37 and
we were unable to determine the relationship between timing
of treatments given during hospitalization and the develop-
ment of CS. The proportion of patients who underwent cardiac
procedures was lower in patients who experienced prehospi-
tal CS, but higher in patients who developed either early or
late CS, than was observed in patients who did not develop
CS. Similar ﬁndings were reported from a study of more than
10 000 patients in the Euro-Heart-Survey ACS between 2000
and 2001.11 We also found considerable differences in the
frequency of use of early PCI and CABG surgery in patients
with prehospital versus late CS and according to the type of
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AMI. Patients who developed prehospital shock were more
likely to have undergone a PCI during the ﬁrst 24 hours of
hospital admission than patients who developed late-onset CS
whereas patients who developed late onset CS were more
likely to have undergone early CABG surgery than patients
who developed prehospital CS. Given the observational nature
of this study, however, and the difﬁculties in interpreting the
relationship between occurrence of CS and the timing of
coronary revascularization, caution should be exercised in the
interpretation of these data. Future studies should more
systematically examine the relation between the timing of
these revascularization procedures and the onset of CS, given
the potential beneﬁts associated with the use of these
interventional procedures.
On the other hand, our ﬁndings differ from the results of
several previous studies. For example, in the AMIS Plus study,
patients with CS, regardless of timing, were less likely to
have received effective cardiac medications, and were more
likely to have received IABP support, compared with patients
without this complication.9 Furthermore, in this study,
patients who developed CS on hospital admission were more
likely (45.4% versus 39.0%), whereas patients who developed
this complication during hospitalization were less likely
(24.6% versus 39.0%), to have undergone a PCI compared
with those who did not develop this complication.9 In the
GRACE study, patients with CS both on admission and during
hospitalization were less likely to have received effective
cardiac medications, but were more likely to have undergone
a PCI and IABP, compared with patients without this
complication.15
In-Hospital Clinical Complications and Death
According to Timing of CS
In the present study, patients who developed CS at all 3 time
points were at signiﬁcantly higher risk for developing other
important clinical complications and dying during their index
hospitalization for AMI compared with patients who did not
develop CS. Indeed, patients who developed late CS were at
more than 20 times higher risk for dying, followed by patients
with prehospital shock (9 times), and those who developed CS
early during their acute hospitalization (8 times), than patients
who did not develop this complication.
Our results are consistent with ﬁndings from the AMIS Plus
registry and the GRACE study, which showed that the CFRs
associated with in-hospital CS were higher than that associ-
ated with prehospital CS.9,15 One possible explanation is that
patients with late CS are more likely to be older, to have more
comorbidities present, and to develop other clinical compli-
cations compared with patients with prehospital CS. The
development of late CS is likely attributed to the failure of the
initial treatments prescribed that protect against the adverse
hemodynamic consequences of a large infarction and asso-
ciated mechanical complications, whereas prehospital CS
may be attributed to arrhythmias or stunned myocardium that
could heal after prompt treatment. In contrast, a report from
the SHOCK (Should We Emergently Revascularize Occluded
Coronaries for Cardiogenic Shock) trial registry (1993–1997)
showed that short-term mortality was higher in patients with
early (<24 hours) versus late CS (≥24 hours; 62.6% versus
53.6%); the latter ﬁndings may be attributed, in part, to
selection bias, in which there was under-representation of
more-complex patients who developed CS.16
Because the use of effective treatments in this study and in
previous studies was somewhat suboptimal, more-aggressive
and timely use of effective cardiac treatment approaches is
encouraged to improve the short-term outcomes of these
high-risk patients.
Study Strengths and Limitations
This study has several strengths, including its population-
based design that captured the vast majority of cases of AMI
that occurred among residents of central Massachusetts. Our
data present a more real-world perspective of decade-long
trends in the magnitude and outcomes associated with the
timing of CS in patients hospitalized with AMI. However, the
absolute number of patients with CS remained relatively small
compared with data from large national registries or multi-
center, randomized trials. Furthermore, because the exact
time of onset of AMI was unable to be determined, CS was
categorized into 3 distinct groups based on the date of
hospital admission, and we were unable to further reﬁne this
time interval because of the manner in which this information
was collected and recorded. The majority of our study
population was white, which may limit the generalizability of
the present ﬁndings, and we did not have information
available about the duration of transport time to each of our
central Massachusetts study hospitals. We did not have
information available on several patient associated charac-
teristics (eg, socioeconomic status), which may have con-
founded some of the observed associations, nor did we
collect information about the use of invasive hemodynamic
monitoring or inotropic or vasopressor agents in this patient
population. Finally, we did not collect information about the
occurrence of out-of-hospital cardiac arrests in residents of
central Massachusetts during the years under study, which
may have affected not only the characteristics of our
hospitalized patient population, but also the declining death
rate we observed in patients with prehospital CS may have
been attributed to changes in both the magnitude and
characteristics of patients who experienced out-of-hospital
cardiac arrest and who survived long enough to be admitted
to central Massachusetts hospitals with an AMI.
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Conclusions
Despite encouraging declines in the death rates associated
with early and late CS in patients hospitalized with AMI, the
death rates associated with prehospital CS increased during
the years under study. This ﬁnding underscores the impor-
tance of the greater attention that needs to be directed to
patients who develop prehospital CS. More-aggressive use of
early coronary revascularization in conjunction with cardiac
support therapies should be encouraged in these patients to
improve their outcomes. Future studies remain needed to
understand the increasing death rates associated with
prehospital CS found in our study, and to inform more-
optimal treatment strategies for the prevention and manage-
ment of CS prehospitalization and during hospitalization for
AMI.
Patients who developed CS regardless of timing experi-
enced high in-hospital death rates. Effective treatments
potentially preventing and treating CS should be encouraged
to be used early and more aggressively in high-risk patient
groups to ensure the optimal utilization of effective treatment
strategies, and to improve patients’ outcomes.
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